ArticleLipids in health and disease2020

Ezetimibe promotes CYP7A1 and modulates PPARs as a compensatory mechanism in LDL receptor-deficient hamsters.

Bin Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.